This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
MOUNTAIN VIEW, Calif.,
Feb. 21, 2013 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its fourth quarter and full year 2012 financial results after the market closes on
Thursday, February 28, 2013. In conjunction with the release, the Company will host a conference call with the investment community at
5:00 p.m. Eastern Time onThursday, February 28, 2013to discuss the results of the quarter and full year and other business developments.
Interested parties may access the live conference call via telephone by dialing (866) 225-8754 U.S. or (480) 629-9818 (International) and quoting Conference ID 4603021, or by visiting the Company's website at
www.iridex.com. A telephone replay will be available beginning on
Thursday, February 28, 2013 through
Thursday, March 7, 2013 by dialing (800) 406-7325 (US) or (303) 590-3030 (International) and entering Access Code 4603021.
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in
the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into 107 countries. For further information, visit the Company's website at